Accium BioSciences Email Format

Pharmaceutical ManufacturingWashington, United States11-50 Employees

Accium BioSciences provides accelerator mass spectrometry (AMS) services to the global pharmaceutical and life sciences sectors. These services support drug development by enabling precise assessment of pharmacokinetics, metabolism, and mass balance through detection of 14C-labeled molecules at very low levels. The company operates the first commercial AMS facility in North America, established in early 2006, and serves major pharmaceutical companies, including five of the top ten global players such as Merck, Novartis, and Bristol-Myers Squibb. 

Its offerings are delivered through three service units—AMS, Bioanalytical, and Quality—allowing clients to mix and match to achieve the right outcome at the right cost. The DirectAMS program is intended to make AMS more accessible and affordable. Based in Seattle, Washington, Accium operates as a small-to-mid-sized company focused on serving the pharmaceutical and life sciences market.

Sign up for free to view info

Company overview Employee directory